Global Pneumonia Testing Market By Type (By Method: Immunodiagnostics , Molecular Diagnostics , Point of Care (POC) Testing , By Technology: Enzyme-linked Immunosorbent Assay (ELISA) , Immunofluorescence , Western Blot , Polymerase Chain Reaction (PCR) , Immunohistochemistry (IHC) , Others , By Type: Analyzers , and Consumables), By Application (Hospitals , Diagnostic Laboratories , Homecare , and Others), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

Overview
Table of Contents
Major Market Players
Inquiry Before Buying

About Me
- Report Code 50763
- Single User $3,495.00
- Multi User $5,100.00
- Corporate Users $7,200.00
Buy Now
Global Pneumonia Testing Market is estimated to be valued US$ XX.X million in 2019. The report on Pneumonia Testing Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global pneumonia testing market is segmented on the basis of type, application, and geography.

Europe market was valued at US$ XX.X million in 2018 and is projected to reach US$ XX.X million in 2029, and register a CAGR of X.X% during the forecast period, according to a new Market.us (Prudour Research) study.

Pneumonia Testing Market Scope:

By type, the market is segmented into By Method: Immunodiagnostics, Molecular Diagnostics, Point of Care (POC) Testing, By Technology: Enzyme-linked Immunosorbent Assay (ELISA), Immunofluorescence, Western Blot, Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Others, By Type: Analyzers, and Consumables. By application, the market is divided into Hospitals, Diagnostic Laboratories, Homecare, and Others.
Request Covid - 19 Impact

Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Thermo Fisher Scientific, Abbott Laboratories, F-Hoffmann la Roche, Hologic, bioMerieux, Becton, Dickenson and Company, Bio-Rad Laboratories, Meridian Biosciences, Quest Diagnostics, Quidel, AdvanDx, Beckman Coulter, Cepheid, Concile, Diamedix, DiaSorin, Fast-track Diagnostics, SeraCare, and Trinity Biotech.

Key Market Segments

Type
- By Method: Immunodiagnostics
- Molecular Diagnostics
- Point of Care (POC) Testing
- By Technology: Enzyme-linked Immunosorbent Assay (ELISA)
- Immunofluorescence
- Western Blot
- Polymerase Chain Reaction (PCR)
- Immunohistochemistry (IHC)
- Others
- By Type: Analyzers
- Consumables
Application
- Hospitals
- Diagnostic Laboratories
- Homecare
- Others
Key Market Players included in the report:
- Thermo Fisher Scientific
- Abbott Laboratories
- F-Hoffmann la Roche
- Hologic
- bioMerieux
- Becton
- Dickenson and Company
- Bio-Rad Laboratories
- Meridian Biosciences
- Quest Diagnostics
- Quidel
- AdvanDx
- Beckman Coulter
- Cepheid
- Concile
- Diamedix
- DiaSorin
- Fast-track Diagnostics
- SeraCare
- Trinity Biotech
Reasons to Get this Report:

In an insight outlook, this research report has dedicated to several quantities of analysis - industry research (global industry trends) and Pneumonia Testing Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Pneumonia Testing Market; high-growth regions; and market drivers, restraints, and also market chances.

The analysis covers Pneumonia Testing Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Pneumonia Testing Market across sections such as also application and representatives.

Additionally, the analysis also has a comprehensive review of the crucial players on the Pneumonia Testing Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

The analysis objectives of the report are:
- To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
- To know the Pneumonia Testing Market by pinpointing its many subsegments.
- To profile the important players and analyze their growth plans.
- To endeavor the amount and value of Pneumonia Testing sub-markets, depending on key regions (various vital states).
- To analyze Pneumonia Testing Market concerning growth trends, prospects, and also their participation in the entire sector.
- To examine and study the Pneumonia Testing Market size (volume & value) from the company, essential regions/countries, products, and application, background information from 2013 to 2018, and also prediction to 2029.
- Primary worldwide Pneumonia Testing Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
- To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.
For the Pneumonia Testing Market research study, the following years have been considered to estimate the market size:
Particular Scope
Region

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

Historic Year 2015 to 2020

Estimated Year 2021

Forecast Year 2022 to 2031
Pneumonia Testing Market

Buy Now Download Sample
About Me
- Report Code 50763
- Single User $3,495.00
- Multi User $5,100.00
- Corporate Users $7,200.00
Buy Now
- 1. Pneumonia Testing Market Introduction
  - 1.1. Definition
  - 1.2. Taxonomy
  - 1.3. Research Scope
- 2. Executive Summary
  - 2.1. Key Findings by Major Segments
  - 2.2. Top strategies by Major Players
- 3. Global Pneumonia Testing Market Overview
  - 3.1. Pneumonia Testing Market Dynamics
    
    3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges
  - 3.2. PESTLE Analysis
  - 3.3. Opportunity Map Analysis
  - 3.4. PORTER'S Five Forces Analysis
  - 3.5. Market Competition Scenario Analysis
  - 3.6. Product Life Cycle Analysis
  - 3.7. Opportunity Orbits
  - 3.8. Production Analysis by Region/Company
  - 3.9. Industry chain Analysis
  - 3.10. Marketing Strategy
- 4. Global Pneumonia Testing Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
  - 4.1. Global Pneumonia Testing Market Analysis by Type: Introduction
  - 4.2. Market Size and Forecast by Region
  - 4.3. By Method: Immunodiagnostics
  - 4.4. Molecular Diagnostics
  - 4.5. Point of Care (POC) Testing
  - 4.6. By Technology: Enzyme-linked Immunosorbent Assay (ELISA)
  - 4.7. Immunofluorescence
  - 4.8. Western Blot
  - 4.9. Polymerase Chain Reaction (PCR)
  - 4.10. Immunohistochemistry (IHC)
  - 4.11. Others
  - 4.12. By Type: Analyzers
  - 4.13. Consumables
- 5. Global Pneumonia Testing Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
  - 5.1. Global Pneumonia Testing Market Analysis by Application: Introduction
  - 5.2. Market Size and Forecast by Region
  - 5.3. Hospitals
  - 5.4. Diagnostic Laboratories
  - 5.5. Homecare
  - 5.6. Others
- 6. Global Pneumonia Testing Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
  - 6.1. North America
    
    6.1.1. North America Pneumonia Testing Market: Regional Trend Analysis
    
    6.1.1.1. US
    
    6.1.1.2. Canada
    
    6.1.1.3. Mexico
  - 6.2.1. Europe
    
    6.2.1. Europe Pneumonia Testing Market: Regional Trend Analysis
    
    6.2.1.1. Germany
    
    6.2.1.2. France
    
    6.2.1.3. UK
    
    6.2.1.4. Russia
    
    6.2.1.5. Italy
    
    6.2.1.6. Spain
    
    6.2.1.7. Rest of Europe
  - 6.3. Asia-Pacific
    
    6.3.1. Asia-Pacific Pneumonia Testing Market: Regional Trend Analysis
    
    6.3.1.1. China
    
    6.3.1.2. Japan
    
    6.3.1.3. Korea
    
    6.3.1.4. India
    
    6.3.1.5. Rest of Asia-Pacific
  - 6.4. Latin America
    
    6.4.1. Latin America Pneumonia Testing Market: Regional Trend Analysis
    
    6.4.1.1. Brazil
    
    6.4.1.2. Argentina
    
    6.4.1.3. Rest of Latin America
  - 6.5. Middle East and Africa
    
    6.5.1. Middle East and Africa Pneumonia Testing Market: Regional Trend Analysis
    
    6.5.1.1. GCC
    
    6.5.1.2. South Africa
    
    6.5.1.3. Israel
    
    6.5.1.4. Rest of MEA
- 7. Global Pneumonia Testing Market Competitive Landscape, Market Share Analysis, and Company Profiles
  - 7.1. Market Share Analysis
  - 7.2. Company Profiles
  - 7.3. Thermo Fisher Scientific
    
    7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments
  - 7.4. Abbott Laboratories
    
    7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments
  - 7.5. F-Hoffmann la Roche
    
    7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments
  - 7.6. Hologic
    
    7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments
  - 7.7. bioMerieux
    
    7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments
  - 7.8. Becton
    
    7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments
  - 7.9. Dickenson and Company
    
    7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments
  - 7.10. Bio-Rad Laboratories
    
    7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments
  - 7.11. Meridian Biosciences
    
    7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments
  - 7.12. Quest Diagnostics
    
    7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments
  - 7.13. Quidel
    
    7.13.1. Company Overview
    
    7.13.2. Financial Highlights
    
    7.13.3. Product Portfolio
    
    7.13.4. SWOT Analysis
    
    7.13.5. Key Strategies and Developments
  - 7.14. AdvanDx
    
    7.14.1. Company Overview
    
    7.14.2. Financial Highlights
    
    7.14.3. Product Portfolio
    
    7.14.4. SWOT Analysis
    
    7.14.5. Key Strategies and Developments
  - 7.15. Beckman Coulter
    
    7.15.1. Company Overview
    
    7.15.2. Financial Highlights
    
    7.15.3. Product Portfolio
    
    7.15.4. SWOT Analysis
    
    7.15.5. Key Strategies and Developments
  - 7.16. Cepheid
    
    7.16.1. Company Overview
    
    7.16.2. Financial Highlights
    
    7.16.3. Product Portfolio
    
    7.16.4. SWOT Analysis
    
    7.16.5. Key Strategies and Developments
  - 7.17. Concile
    
    7.17.1. Company Overview
    
    7.17.2. Financial Highlights
    
    7.17.3. Product Portfolio
    
    7.17.4. SWOT Analysis
    
    7.17.5. Key Strategies and Developments
  - 7.18. Diamedix
    
    7.18.1. Company Overview
    
    7.18.2. Financial Highlights
    
    7.18.3. Product Portfolio
    
    7.18.4. SWOT Analysis
    
    7.18.5. Key Strategies and Developments
  - 7.19. DiaSorin
    
    7.19.1. Company Overview
    
    7.19.2. Financial Highlights
    
    7.19.3. Product Portfolio
    
    7.19.4. SWOT Analysis
    
    7.19.5. Key Strategies and Developments
  - 7.20. Fast-track Diagnostics
    
    7.20.1. Company Overview
    
    7.20.2. Financial Highlights
    
    7.20.3. Product Portfolio
    
    7.20.4. SWOT Analysis
    
    7.20.5. Key Strategies and Developments
  - 7.21. SeraCare
    
    7.21.1. Company Overview
    
    7.21.2. Financial Highlights
    
    7.21.3. Product Portfolio
    
    7.21.4. SWOT Analysis
    
    7.21.5. Key Strategies and Developments
  - 7.22. Trinity Biotech
    
    7.22.1. Company Overview
    
    7.22.2. Financial Highlights
    
    7.22.3. Product Portfolio
    
    7.22.4. SWOT Analysis
    
    7.22.5. Key Strategies and Developments
- 8. Assumptions and Acronyms
- 9. Research Methodology
- 10. Contact
Videos
- Report Code 50763
- Single User $3,495.00
- Multi User $5,100.00
- Corporate Users $7,200.00
Buy Now
- Thermo Fisher Scientific
- Abbott Laboratories
- F-Hoffmann la Roche
- Hologic
- bioMerieux
- Becton
- Dickenson and Company
- Bio-Rad Laboratories
- Meridian Biosciences
- Quest Diagnostics
- Quidel
- AdvanDx
- Beckman Coulter
- Cepheid
- Concile
- Diamedix
- DiaSorin
- Fast-track Diagnostics
- SeraCare
- Trinity Biotech
Settings
- Name
- Email
- Company
- Designation
- Country
- Phone
- Message